HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 288 filers reported holding HAEMONETICS CORP in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $829,153 | +2.8% | 9,256 | -2.3% | 0.00% | +50.0% |
| Q2 2023 | $806,361 | +9.5% | 9,471 | +6.4% | 0.00% | 0.0% |
| Q1 2023 | $736,558 | -10.1% | 8,901 | -14.6% | 0.00% | -33.3% |
| Q4 2022 | $819,454 | +20.3% | 10,419 | +13.0% | 0.00% | 0.0% |
| Q3 2022 | $681,000 | +11.6% | 9,219 | -1.4% | 0.00% | +50.0% |
| Q2 2022 | $610,000 | -33.7% | 9,353 | -35.7% | 0.00% | 0.0% |
| Q1 2022 | $920,000 | +2.6% | 14,547 | -14.0% | 0.00% | 0.0% |
| Q4 2021 | $897,000 | +13.5% | 16,916 | +51.1% | 0.00% | 0.0% |
| Q3 2021 | $790,000 | -36.9% | 11,192 | -40.4% | 0.00% | -50.0% |
| Q2 2021 | $1,251,000 | +131.7% | 18,779 | +286.0% | 0.00% | +100.0% |
| Q1 2021 | $540,000 | -7.1% | 4,865 | -0.5% | 0.00% | 0.0% |
| Q4 2020 | $581,000 | +54.9% | 4,889 | +13.7% | 0.00% | 0.0% |
| Q3 2020 | $375,000 | +1.1% | 4,299 | +3.6% | 0.00% | 0.0% |
| Q2 2020 | $371,000 | -35.0% | 4,148 | -27.6% | 0.00% | -50.0% |
| Q1 2020 | $571,000 | -60.1% | 5,730 | -54.0% | 0.00% | -42.9% |
| Q4 2019 | $1,430,000 | +4.5% | 12,449 | +14.7% | 0.01% | -12.5% |
| Q3 2019 | $1,368,000 | +5.7% | 10,849 | +0.9% | 0.01% | 0.0% |
| Q2 2019 | $1,294,000 | +25.0% | 10,749 | -9.2% | 0.01% | +33.3% |
| Q1 2019 | $1,035,000 | -0.8% | 11,834 | +13.5% | 0.01% | -14.3% |
| Q4 2018 | $1,043,000 | -26.9% | 10,422 | -16.3% | 0.01% | -30.0% |
| Q3 2018 | $1,427,000 | +24.6% | 12,451 | -2.5% | 0.01% | +25.0% |
| Q2 2018 | $1,145,000 | +57.9% | 12,764 | +28.8% | 0.01% | +60.0% |
| Q1 2018 | $725,000 | +14.2% | 9,909 | -9.4% | 0.01% | +25.0% |
| Q4 2017 | $635,000 | +140.5% | 10,932 | +85.8% | 0.00% | +100.0% |
| Q3 2017 | $264,000 | +2.7% | 5,883 | -9.6% | 0.00% | -33.3% |
| Q2 2017 | $257,000 | -22.8% | 6,507 | -20.7% | 0.00% | 0.0% |
| Q1 2017 | $333,000 | -18.0% | 8,207 | -18.8% | 0.00% | -25.0% |
| Q4 2016 | $406,000 | +64.4% | 10,109 | +48.1% | 0.00% | +33.3% |
| Q3 2016 | $247,000 | -6.4% | 6,826 | -24.9% | 0.00% | 0.0% |
| Q2 2016 | $264,000 | -12.3% | 9,094 | +5.8% | 0.00% | -25.0% |
| Q1 2016 | $301,000 | -12.5% | 8,594 | -19.5% | 0.00% | 0.0% |
| Q4 2015 | $344,000 | +37.6% | 10,682 | +38.0% | 0.00% | 0.0% |
| Q3 2015 | $250,000 | -41.2% | 7,740 | -24.7% | 0.00% | -33.3% |
| Q2 2015 | $425,000 | -33.0% | 10,276 | -27.2% | 0.01% | -14.3% |
| Q1 2015 | $634,000 | +13.6% | 14,114 | -5.4% | 0.01% | +16.7% |
| Q4 2014 | $558,000 | -31.8% | 14,922 | -36.3% | 0.01% | -45.5% |
| Q3 2014 | $818,000 | -20.5% | 23,425 | -19.7% | 0.01% | -15.4% |
| Q2 2014 | $1,029,000 | -42.3% | 29,175 | -46.7% | 0.01% | -40.9% |
| Q1 2014 | $1,782,000 | +604.3% | 54,692 | +812.4% | 0.02% | +450.0% |
| Q4 2013 | $253,000 | -81.7% | 5,994 | -82.7% | 0.00% | -87.9% |
| Q3 2013 | $1,385,000 | -7.5% | 34,723 | -4.1% | 0.03% | +13.8% |
| Q2 2013 | $1,497,000 | – | 36,211 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Millrace Asset Group, Inc. | 19,264 | $1,726 | 2.13% |
| Parkman Healthcare Partners LLC | 88,962 | $7,969,216 | 1.46% |
| HEARTLAND ADVISORS INC | 256,414 | $24,435,274 | 1.37% |
| Riverwater Partners LLC | 15,553 | $1,393,238 | 1.27% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 111,100 | $9,952,338 | 1.15% |
| Lisanti Capital Growth, LLC | 78,425 | $7,025,312 | 1.11% |
| Aristotle Capital Boston, LLC | 311,666 | $27,919,054 | 0.90% |
| ROYCE & ASSOCIATES LP | 947,550 | $84,881,529 | 0.86% |
| CHASE INVESTMENT COUNSEL CORP | 18,770 | $1,681 | 0.84% |
| Virtus Investment Advisers, Inc. | 13,662 | $1,223,842 | 0.83% |